Article
Use of endotypes, phenotypes, and inflammatory markers to guide treatment decisions in chronic rhinosinusitis.
Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology - 1 Apr 2020
Staudacher Anna G, Peters Anju T, Kato Atsushi, Stevens Whitney W
Abstract excerpt
OBJECTIVE: With the advent of new treatment options for Chronic Rhinosinusitis (CRS) comes the ability for physicians to provide more individualized patient care. Physicians are now tasked with identifying who may be the best candidate for a particular therapy. In this review, existing biomarkers and potentially new methods that could guide treatment choices in CRS patients will be discussed. DATA SOURCES:...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.